Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? | Brain Sci | 2025 | 41008338 | PubTator, text mining | PubMed |
| 89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism. | EJNMMI Res | 2025 | 41003920 | PubTator, text mining | PubMed |
| Albumin/Hyaluronic Acid Gel Nanoparticles Loaded with a Pyrimidine-Based Drug for Potent Anticancer Activity. | Gels | 2025 | 41002533 | PubTator, text mining | PubMed |
| Novel BCR-Targeting Fusion Proteins for Antigen-Specific Depletion of Alloreactive B Cells in Antibody-Mediated Rejection. | Cells | 2025 | 41002377 | PubTator, text mining | PubMed |
| Site-specific adaptive nanovesicles for oral insulin delivery. | Sci Adv | 2025 | 40991712 | PubTator, text mining | PubMed |
| Identification of High-Risk Population for Mortality and Severe Clinical Outcomes Among Patients With Myasthenia Gravis: A Nationwide Population-Based Cohort Study in Korea. | J Korean Med Sci | 2025 | 40985852 | PubTator, text mining | PubMed |
| Advances and challenges in research methods on oral absorption mechanisms of nano-formulations. | PeerJ | 2025 | 40980070 | PubTator, text mining | PubMed |
| Hemolytic Disease of the Fetus and Newborn: Fetal RHD Genotyping, Targeted Prophylaxis, and Prenatal Therapies. | Prenat Diagn | 2025 | 40973699 | PubTator, text mining | PubMed |
| Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy. | Acta Neuropathol | 2025 | 40971018 | PubTator, text mining | PubMed |
Cross-Species Extrapolation of Neonatal Fc Receptor (FcRn) Binding Affinity to Predict Monoclonal Antibody Pharmacokinetics in Humans Using Physiologically Based Pharmacokinetic Modeling (PBPK): Are We There Yet? | ACS Pharmacol Transl Sci | 2025 | 40969885 | PubTator, text mining | PubMed |
| Nipocalimab Dose Selection in Generalized Myasthenia Gravis. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40960093 | PubTator, text mining | PubMed |
| Repetitive nerve stimulation normalization after FcRn inhibitor therapy in refractory myasthenia gravis: A case report. | Clin Neurophysiol | 2025 | 40945233 | PubTator, text mining | PubMed |
| Efficacy and safety of efgartigimod versus intravenous immunoglobulin in early intervention of acetylcholine receptor antibody-positive impending myasthenic crisis: A retrospective cohort study. | Neurotherapeutics | 2025 | 40914739 | PubTator, text mining | PubMed |
| [Future directions in the management of warm autoimmune hemolytic anemia]. | Rinsho Ketsueki | 2025 | 40903253 | PubTator, text mining | PubMed |
| Transplacental transfer of maternal SARS-CoV-2 antibodies in dichorionic and monochorionic twin pregnancies. | PLoS One | 2025 | 40892764 | PubTator, text mining | PubMed |
| Successful sequential treatment with ofatumumab followed by efgartigimod for refractory autoimmune encephalitis with dual anti-NMDAR and anti-GFAP antibody positivity: first case report. | Front Immunol | 2025 | 40881715 | PubTator, text mining | PubMed |
| Molecular basis of potent antiviral HLA-C-restricted CD8+ T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope. | Nat Commun | 2025 | 40877317 | PubTator, text mining | PubMed |
| Enhancement of Protein-Protein Interactions by Destabilizing Mutations Revealed by HDX-MS. | Biomolecules | 2025 | 40867645 | PubTator, text mining | PubMed |
| Anti-CD19/CD20 bispecific antibody with dual Fc domains mediates enhanced effector functions and durable depletion of memory B cells in vivo. | Sci Rep | 2025 | 40866422 | PubTator, text mining | PubMed |
| A Novel Anti-BoNT/A Neutralizing Antibody Possessed Overlapped Epitope with SV2 and Had Prolonged Half-Life In Vivo. | Toxins (Basel) | 2025 | 40864052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=16